You are here
MHRP researchers and Thai collaborators discuss RV254/SEARCH 010, which is providing knowledge about the earliest HIV events that may provide clues to developing an effective HIV vaccine or even help identify ways to achieve a functional cure.
In Thailand, MHRP researchers collaborate with the Thai Red Cross AIDS Research Center to identify acutely infected individuals and place them onto ART immediately. Researchers have found that this very early initiation of ART results in immune restoration and a very small or undetectable reservoir of HIV DNA, very similar characteristics to “elite” HIV controllers.
As of early 2016, samples from more than 170,000 individuals have been collected from voluntary testing and counseling clinics in Bangkok. Samples found to be negative with routine testing then underwent a Nucleic Acid Test (NAT). So far, 339 people found to be acutely infected have been enrolled in this cohort, and nearly all of them opted to start ART within days of discovering their status.
MHRP was a founding member of the International Neurological HIV Cure Consortium (INHCC), an international alliance dedicated to studying HIV’s impact on the central nervous system in the hopes of leveraging those findings to discover a cure for HIV. Using MHRP’s novel acute cohorts, INHCC has launched a number of studies aimed at determining the immediate and long-term cognitive and behavioral impacts of acute HIV infection.
Protocol Chair: Dr. Jintanat Ananworanich